| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |